Repurposing Bedaquiline for Effective Non-Small Cell Lung Cancer (NSCLC) Therapy as Inhalable Cyclodextrin-Based Molecular Inclusion Complexes NKK Vineela Parvathaneni, Rasha S. Elbatanony, Mimansa Goyal, Tejashri ... International Journal of Molecular Sciences 22 (9), 4783, 2021 | 28 | 2021 |
Development of gelatin methacrylate (GelMa) hydrogels for versatile intracavitary applications NS Kulkarni, G Chauhan, M Goyal, S Sarvepalli, V Gupta Biomaterials Science 10 (16), 4492-4507, 2022 | 24 | 2022 |
Cationically modified inhalable nintedanib niosomes: enhancing therapeutic activity against non-small-cell lung cancer S K Shukla, V Nguyen, M Goyal, V Gupta Nanomedicine 17 (13), 935-958, 2022 | 21 | 2022 |
Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC) VG Vineela Parvathaneni, Mimansa Goyal American Journal of Respiratory and Critical Care Medicine, 2019 | 21* | 2019 |
Small-molecule Gankyrin inhibition as a therapeutic strategy for breast and lung cancer D Kanabar, M Goyal, EI Kane, T Chavan, A Kabir, X Wang, S Shukla, ... Journal of medicinal chemistry 65 (13), 8975-8997, 2022 | 8 | 2022 |
Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment M Goyal, G Tulsyan, DD Kanabar, T Chavan, A Muth, V Gupta Journal of Drug Delivery Science and Technology 87, 104767, 2023 | 5 | 2023 |
A Nanoemulgel for Nose-to-Brain delivery of Quetiapine–QbD-Enabled formulation development & in-vitro characterization D Gadhave, M Quadros, AR Ugale, M Goyal, V Gupta International Journal of Pharmaceutics 648, 123566, 2023 | 4 | 2023 |
Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine–Development & characterization in physiologically relevant 3D tissue models DG Gadhave, M Quadros, AR Ugale, M Goyal, S Ayehunie, V Gupta International Journal of Biological Macromolecules 267, 131491, 2024 | 2 | 2024 |
Inhaled nintedanib nanoparticles for enhanced efficacy in idiopathic pulmonary fibrosis (IPF) treatment–Evidence in disease-relevant in-vitro models X Wang, M Goyal, D Gadhave, V Gupta Journal of Drug Delivery Science and Technology 95, 105615, 2024 | 2 | 2024 |
Excipients for Novel Inhaled Dosage Forms: An Overview C Yousry, M Goyal, V Gupta AAPS PharmSciTech 25 (2), 36, 2024 | 1 | 2024 |
Continuously producible aztreonam-loaded inhalable lipid nanoparticles for cystic fibrosis-associated Pseudomonas aeruginosa infections–Development and in-vitro characterization G Chauhan, AA Shaik, SS Sawant, R Diwan, M Mokashi, M Goyal, ... Biomaterials Advances 166, 214027, 2025 | | 2025 |
Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex SK Shukla, M Goyal, DD Kanabar, S Ayehunie, B Deore, CA Sanhueza, ... Journal of Molecular Liquids 401, 124701, 2024 | | 2024 |
Synthesis and evaluation of 2, 5-substituted pyrimidines as small-molecule gankyrin binders D Kanabar, EI Kane, T Chavan, TM Laflamme, E Suarez, M Goyal, ... Future Medicinal Chemistry 16 (3), 239-251, 2024 | | 2024 |
Approaches for drug delivery to the mitochondria: current status and future trends M Goyal, V Parvathaneni, V Gupta Multifunctional Nanocarriers, 261-288, 2022 | | 2022 |